The global naloxone spray market size is expected to reach US$ 1.3 billion by 2031. Narcan nasal spray of Naloxone got the FDA sanction in November 2015. Naloxone is a drug which is for the most part used to treat the narcotic excess consumption like morphine and diacetylmorphine.
It is important to give crisis clinical assistance to the patient after giving the main dose of the nasal spray. As indicated by the Centers for Disease Control and Prevention, around 400,000 individuals died because of a narcotic overdose in the period 1999 to 2017. Naloxone Nasal Spray is an essential medical component of drug or medication overdose kit in virtue of its quick response and effective effect on the symptoms of overdose.
As stated by various government sources, in 50 US states, the spray might be employed without the requirement for a prescription from medical experts in near future. In 2018, New BioSolutions merged Adapt Pharma for potential upcoming opportunities taken into consideration during the year 2022-2032. Moreover, proactive initiatives taken by different organizations and associations to expatiate reach of Naloxone is relied upon to fuel the market development in coming years.
However, Naloxone is a new item introduced recently in medical and healthcare sector, the significant expense related to manufacturing and dispersion of this item combined with the lack of detailed research results available regarding adverse effects, are expected to cause obstructions in the market development during the forecast period of 2022-2032.
Global Naloxone Spray Market Value Share Analysis, by Geography (2021)
The report titled “Global Naloxone Spray Market - Global Market Share, Trends, Analysis and Forecasts, 2022-2032”, wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the Global Naloxone Spray Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global Naloxone Spray market is segmented based on product type, and application type, and region. Based on product type, the Naloxone Spray market is segmented into 2 mg/actuation, 4 mg/actuation, others. Based on End user type, the Naloxone Spray market is segmented into Retail Pharmacies, Online Pharmacies, Hospitals & Clinics, Rehab Centers, Home Care Settings, others.
Based on geography, the Global Naloxone Spray Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada, and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Italy, France, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on Global Naloxone Spray Market. Further, market share of prominent companies in the Global Naloxone Spray Market would also be estimated.
The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Naloxone Spray companies. The Global Naloxone Spray Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the Naloxone Spray business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the Global Naloxone Spray Market.
The key players of the Global Naloxone Spray Market are Medline Industries, Inc.; Emergent BioSolutions, Pfizer, and Teva Pharmaceuticals Industries Ltd. and others.
Global Naloxone Spray Market Key Segments:
By Product type
By End user type
By Region
The global naloxone spray market size is expected to reach US$ 1.3 billion by 2032.
The end-use segments in Naloxone Spray market are Hospitals & Clinics, Rehab Centers and Home Care Settings.
Medline Industries, Inc.; Emergent BioSolutions, Pfizer, and Teva Pharmaceuticals Industries Ltd. are few prominent players active in the market.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved